Literature DB >> 2176177

The human MyoD1 (MYF3) gene maps on the short arm of chromosome 11 but is not associated with the WAGR locus or the region for the Beckwith-Wiedemann syndrome.

M Gessler1, H Hameister, I Henry, C Junien, T Braun, H H Arnold.   

Abstract

The human gene encoding the myogenic determination factor myf3 (mouse MyoD1) has been mapped to the short arm of chromosome 11. Analysis of several somatic cell hybrids containing various derivatives with deletions or translocations revealed that the human MyoD (MYF3) gene is not associated with the WAGR locus at chromosomal band 11p13 nor with the loss of the heterozygosity region at 11p15.5 related to the Beckwith-Wiedemann syndrome. Subregional mapping by in situ hybridization with an myf3 specific probe shows that the gene resides at the chromosomal band 11p14, possibly at 11p14.3.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2176177     DOI： 10.1007/BF00197694

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  31 in total

1.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

2.  DNA replication patterns of human chromosomes from fibroblasts and amniotic fluid cells revealed by a Giemsa staining technique.

Authors:  J T Epplen; J W Siebers; W Vogel
Journal:  Cytogenet Cell Genet       Date:  1975

3.  Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.

Authors:  A Koufos; P Grundy; K Morgan; K A Aleck; T Hadro; B C Lampkin; A Kalbakji; W K Cavenee
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

4.  Long range physical map of the Wilms' tumor-aniridia region on human chromosome 11.

Authors:  D A Compton; M M Weil; C Jones; V M Riccardi; L C Strong; G F Saunders
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

5.  Genetic linkage of Beckwith-Wiedemann syndrome to 11p15.

Authors:  A J Ping; A E Reeve; D J Law; M R Young; M Boehnke; A P Feinberg
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

6.  Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma.

Authors:  I Henry; S Grandjouan; P Couillin; F Barichard; C Huerre-Jeanpierre; T Glaser; T Philip; G Lenoir; J L Chaussain; C Junien
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Characterization of a panel of somatic cell hybrids for subregional mapping along 11p and within band 11p13. Subdivision of the WAGR complex region.

Authors:  P Couillin; M Azoulay; I Henry; N Ravisé; M C Grisard; C Jeanpierre; F Barichard; P Metezeau; J J Candelier; W Lewis
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

8.  Cancer in survivors of childhood soft tissue sarcoma and their relatives.

Authors:  L C Strong; M Stine; T L Norsted
Journal:  J Natl Cancer Inst       Date:  1987-12       Impact factor: 13.506

9.  Molecular differential pathology of rhabdomyosarcoma.

Authors:  H Scrable; D Witte; H Shimada; T Seemayer; W W Sheng; S Soukup; A Koufos; P Houghton; B Lampkin; W Cavenee
Journal:  Genes Chromosomes Cancer       Date:  1989-09       Impact factor: 5.006

10.  Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12.

Authors:  T Braun; E Bober; B Winter; N Rosenthal; H H Arnold
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598
View more
  2 in total

Review 1.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  A variant of Freeman-Sheldon syndrome maps to 11p15.5-pter.

Authors:  P A Krakowiak; J R O'Quinn; J F Bohnsack; W S Watkins; J C Carey; L B Jorde; M Bamshad
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.